U.S. offers to fund new drug trials
The U.S. government is trying to lure pharmaceutical companies into investing in risker medial research by offering to pay for and carry out early clinical trials of experimental drugs. The clinical
The U.S. government is trying to lure pharmaceutical companies into investing in risker medial research by offering to pay for and carry out early clinical trials of experimental drugs. The clinical